Rigel Pharma (RIGL) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $48.67 +0.35%
EPS Growth %: -34.9%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
PMCB, CULP, HURC, More
EPS Growth %: -34.9%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $26.1 million versus the consensus estimate of $23.55 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- UBS Reiterates Buy Rating on PVH Corp (PVH) on Strong Earnings Growth Potential
- Goldman Sachs sees bond markets as speed limiter for stocks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
